| John Patton Ltd | |
|
1775 Browning Way, Suite 101, Elko, NV 89801-8338 | |
| (775) 753-4044 | |
| (775) 753-5694 |
| Full Name | John Patton Ltd |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 1775 Browning Way, Elko, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093018616 | NPI | - | NPPES |
| DR4064 | Other | RR MEDICARE PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | (Nevada) | Primary |
| Provider Name | John Patrick Patton |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1649367194 PECOS PAC ID: 2264565795 Enrollment ID: I20100803001379 |
News Archive
Patients with infective endocarditis involving implanted cardiac devices experience a high rate of complications such as valve infections, heart failure, and persistent bacteremia, and high in-hospital and 1-year mortality rates, particularly if there is valve involvement, according to a study in the April 25 issue of JAMA.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced 11 posters on entinostat, an oral, highly selective, class I histone deacetylase inhibitor, will be presented at the 102nd Annual American Association for Cancer Research meeting April 2 to April 6 in Orlando, FL.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).
Japanese researchers have developed and tested a prototype device - wearable on the fingertips - that incorporates the concept of 'light touch' to enhance the sense of balance. If widely implemented, the device should significantly reduce incidence of falls amongst seniors.
Today the U.S. Food and Drug Administration proposed the Innovation Pathway, a priority review program for new, breakthrough medical devices and announced the first submission: a brain-controlled, upper-extremity prosthetic that will serve as a pilot for the program. The FDA also announced plans to seek further public comment before the Pathway can be used more broadly.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Patton Ltd 1775 Browning Way, Suite 101, Elko, NV 89801-8338 Ph: (775) 753-4044 | John Patton Ltd 1775 Browning Way, Suite 101, Elko, NV 89801-8338 Ph: (775) 753-4044 |
News Archive
Patients with infective endocarditis involving implanted cardiac devices experience a high rate of complications such as valve infections, heart failure, and persistent bacteremia, and high in-hospital and 1-year mortality rates, particularly if there is valve involvement, according to a study in the April 25 issue of JAMA.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced 11 posters on entinostat, an oral, highly selective, class I histone deacetylase inhibitor, will be presented at the 102nd Annual American Association for Cancer Research meeting April 2 to April 6 in Orlando, FL.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).
Japanese researchers have developed and tested a prototype device - wearable on the fingertips - that incorporates the concept of 'light touch' to enhance the sense of balance. If widely implemented, the device should significantly reduce incidence of falls amongst seniors.
Today the U.S. Food and Drug Administration proposed the Innovation Pathway, a priority review program for new, breakthrough medical devices and announced the first submission: a brain-controlled, upper-extremity prosthetic that will serve as a pilot for the program. The FDA also announced plans to seek further public comment before the Pathway can be used more broadly.
› Verified 5 days ago
Draper & Patton Ltd. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1775 Browning Way Ste 101, Elko, NV 89801 Phone: 775-753-4044 Fax: 775-753-5694 | |
Draper And Patton, Ltd Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1775 Browning Way Ste 101, Elko, NV 89801 Phone: 775-753-4044 | |
Shane Draper Ltd Podiatrist Medicare: Medicare Enrolled Practice Location: 1995 Errecart Blvd, Suite #200, Elko, NV 89801 Phone: 775-738-1100 Fax: 775-738-1101 | |
Dr. John Patrick Patton, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1775 Browning Way, Suite 101, Elko, NV 89801 Phone: 775-753-4044 Fax: 775-753-5694 | |
Shane D. Draper, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1995 Errecart Blvd, #200, Elko, NV 89801 Phone: 775-738-1100 Fax: 775-738-1101 |